Retatrutide titration: 1mg to 12mg The retatrutide titration protocol tested in Phase 3 trials follows a five-step escalation: Weeks 1-4: 1mg weekly Weeks 5-8: 2mg weekly Weeks 9-12: 4mg weekly Weeks 13-16: 8mg weekly Week 17 onward: 12mg weekly (maximum dose) The dose doubles at each step (with the exception of the 1mg to 2mg increase), which is a faster escalation rate than either semaglutide or tirzepatide
However, semaglutide C max was higher for IcoSema vs
That said, some preclinical research has explored oral BPC-157 in the context of gastrointestinal health, where localized gut exposure may be relevant
Side Effects OZEMPIC Semaglutide 0.5mg common side effects include: nausea, diarrhea, vomiting, abdominal pain, and constipation
The most common side effects are gastrointestinal symptoms including nausea, diarrhea, and abdominal discomfort, which may be additive when both medications are used together
This flexibility gives patients financial options similar to insurance coverage while maintaining complete control over their healthcare decisions and treatment timeline